Abraham Chesed serves as Executive at Turn Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Abraham Chesed has executed 1 insider transactions totaling $65.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 23, 2025 involved purchasing 14,286 shares valued at $65.7K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 23, 2025 | TTRX | $65.7K | Purchase | 14,286 | $4.60 | Discretionary |
Abraham Chesed currently holds 1,447,268 shares of Turn Therapeutics Inc. (TTRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Abraham Chesed has been a net buyer of TTRX stock. They have purchased $65.7K and sold $0 worth of shares.
Abraham Chesed's most recent insider trade was on Oct 23, 2025, when they purchased 14,286 shares at $4.60 per share.
Get notified when new Form 4 filings are submitted